marketcaparena
Search

    STAA

    STAAR SURGICAL CO

    Company overview

    Market capitalization
    $1.05B
    Employees
    921
    Latest publication
    2026-09-29
    About STAAR SURGICAL CO

    STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-07-03 · USDQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ4 20232023-12-31 · USDQ3 20232023-09-30 · USDQ2 20232023-06-30 · USD
    Total Revenue93,535,000USD93,522,000USD94,732,000USD88,590,000USD99,005,000USD76,273,000USD80,308,000USD92,306,000USD
    Cost Of Revenue23,808,000USD25,999,000USD16,857,000USD20,103,000USD20,593,000USD15,548,000USD16,670,000USD21,580,000USD
    Gross Profit69,727,000USD67,523,000USD77,875,000USD68,487,000USD78,412,000USD60,725,000USD63,638,000USD70,726,000USD
    Research Development9,943,000USD9,716,000USD9,209,000USD14,497,000USD11,868,000USD10,866,000USD11,470,000USD11,755,000USD
    Selling General Administrative59,626,000USD17,022,000USD20,763,000USD21,685,000USD23,641,000USD16,858,000USD19,266,000USD18,097,000USD
    Selling And Marketing Expenses26,944,000USD23,382,000USD23,461,000USD26,623,000USD31,005,000USD22,596,000USD26,607,000USD32,277,000USD
    General And Administrative Expenses22,739,000USD———————
    Total Operating Expenses59,626,000USD50,120,000USD59,385,000USD62,805,000USD66,514,000USD50,320,000USD57,343,000USD62,129,000USD
    Operating Income10,101,000USD17,403,000USD18,490,000USD5,682,000USD11,898,000USD10,405,000USD6,295,000USD8,597,000USD
    Total Other Income Expense Net923,000USD-9,185,000USD300,000USD7,477,000USD-1,564,000USD3,334,000USD451,000USD-105,000USD
    Income Before Tax11,024,000USD8,218,000USD18,790,000USD13,159,000USD10,334,000USD13,739,000USD6,746,000USD8,492,000USD
    Income Tax Expense2,966,000USD3,012,000USD9,906,000USD3,179,000USD2,955,000USD5,983,000USD1,929,000USD2,428,000USD
    Net Income8,058,000USD5,206,000USD8,884,000USD9,980,000USD7,379,000USD7,756,000USD4,817,000USD6,064,000USD
    Net Interest Income—907,000USD790,000USD1,407,000USD1,422,000USD1,529,000USD1,699,000USD1,690,000USD
    Tax Provision—3,012,000USD9,906,000USD3,179,000USD2,955,000USD1,128,000USD5,983,000USD1,929,000USD
    Net Income From Continuing Ops—5,206,000USD8,884,000USD9,980,000USD7,379,000USD-3,339,000USD7,756,000USD4,817,000USD
    Ebit—8,218,000USD24,442,000USD13,159,000USD10,334,000USD13,739,000USD6,746,000USD8,492,000USD
    Ebitda—10,429,000USD26,442,000USD14,916,000USD11,856,000USD14,951,000USD8,089,000USD9,941,000USD
    Depreciation And Amortization—2,211,000USD2,000,000USD1,757,000USD1,522,000USD1,212,000USD1,343,000USD1,449,000USD
    Reconciled Depreciation—2,211,000USD2,000,000USD1,757,000USD1,522,000USD1,237,000USD1,212,000USD1,343,000USD
    Unclassified Operating Expenses——5,952,000USD—————
    Interest Income——790,000USD—1,422,000USD1,529,000USD—1,775,000USD
    Interest Expense—————1,822,000USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20132013-12-31 · USDFY 20112011-12-31 · USD
    Total Revenue322,415,000USD284,391,000USD230,472,000USD163,460,000USD150,185,000USD123,954,000USD72,215,000USD62,765,000USD
    Cost Of Revenue69,764,000USD61,008,000USD51,835,000USD45,098,000USD38,231,000USD32,444,000USD21,906,000USD20,396,000USD
    Gross Profit252,651,000USD223,383,000USD178,637,000USD118,362,000USD111,954,000USD91,510,000USD50,309,000USD42,369,000USD
    Research Development44,401,000USD35,983,000USD33,862,000USD31,918,000USD25,298,000USD22,028,000USD6,708,000USD5,868,000USD
    Selling General Administrative72,319,000USD54,742,000USD44,142,000USD33,911,000USD29,313,000USD24,287,000USD18,810,000USD15,992,000USD
    Selling And Marketing Expenses107,834,000USD88,856,000USD67,294,000USD45,764,000USD45,491,000USD38,600,000USD23,888,000USD17,726,000USD
    Total Operating Expenses224,554,000USD179,581,000USD145,298,000USD111,593,000USD100,102,000USD84,915,000USD49,609,000USD39,586,000USD
    Operating Income28,097,000USD43,802,000USD33,339,000USD6,769,000USD11,852,000USD6,595,000USD700,000USD2,783,000USD
    Interest Income6,986,000USD2,448,000USD—238,000USD988,000USD———
    Net Interest Income6,986,000USD2,448,000USD-38,000USD238,000USD988,000USD165,000USD——
    Income Before Tax33,696,000USD45,552,000USD31,304,000USD8,267,000USD13,026,000USD6,639,000USD1,114,000USD2,704,000USD
    Income Tax Expense12,349,000USD5,887,000USD3,793,000USD2,354,000USD-1,022,000USD1,671,000USD716,000USD1,356,000USD
    Tax Provision12,349,000USD6,797,000USD6,803,000USD2,354,000USD-1,022,000USD1,671,000USD——
    Net Income21,347,000USD39,665,000USD27,511,000USD5,913,000USD14,048,000USD4,968,000USD398,000USD1,348,000USD
    Net Income From Continuing Ops21,347,000USD39,005,000USD24,501,000USD5,913,000USD14,048,000USD4,968,000USD398,000USD1,348,000USD
    Ebit33,696,000USD45,552,000USD31,342,000USD6,769,000USD11,852,000USD6,595,000USD1,284,000USD3,227,000USD
    Ebitda38,820,000USD50,061,000USD34,984,000USD9,864,000USD15,551,000USD9,059,000USD3,435,000USD5,493,000USD
    Depreciation And Amortization5,124,000USD4,509,000USD3,642,000USD3,095,000USD3,699,000USD2,464,000USD2,151,000USD2,266,000USD
    Reconciled Depreciation5,124,000USD4,509,000USD3,642,000USD3,095,000USD3,699,000USD2,464,000USD——
    Total Other Income Expense Net5,599,000USD1,750,000USD-2,035,000USD1,498,000USD1,174,000USD44,000USD414,000USD-79,000USD
    Interest Expense—2,448,000USD38,000USD2,362,000USD657,000USD165,000USD170,000USD523,000USD
    Net Income Applicable To Common Shares—38,755,000USD24,501,000USD5,913,000USD14,048,000USD4,968,000USD398,000USD1,348,000USD
    Non Operating Income Net Other———1,260,000USD186,000USD-121,000USD584,000USD444,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-07-03 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets475,205,000USD451,118,000USD461,619,000USD456,362,000USD437,781,000USD457,364,000USD509,524,000USD537,590,000USD
    Cash And Equivalents148,579,000USD———————
    Cash And Short Term Investments181,489,000USD163,889,000USD187,536,000USD192,660,000USD189,883,000USD222,761,000USD230,494,000USD235,958,000USD
    Short Term Investments32,910,000USD32,025,000USD34,386,000USD16,505,000USD22,752,000USD49,647,000USD86,335,000USD71,955,000USD
    Total Current Assets342,353,000USD312,398,000USD311,545,000USD321,209,000USD292,792,000USD326,498,000USD367,940,000USD397,106,000USD
    Other Current Assets206,000USD13,031,000USD13,906,000USD11,678,000USD12,722,000USD12,897,000USD14,879,000USD12,796,000USD
    Other Non Current Assets1,226,000USD———————
    Total Liabilities109,807,000USD———————
    Total Current Liabilities73,394,000USD60,994,000USD68,504,000USD61,637,000USD59,228,000USD68,356,000USD70,306,000USD66,341,000USD
    Other Current Liabilities37,542,000USD———————
    Total Stockholder Equity365,398,000USD352,366,000USD344,184,000USD353,780,000USD336,573,000USD349,972,000USD397,335,000USD428,122,000USD
    Total Equity Including Noncontrolling Interest365,398,000USD———————
    Net Receivables98,475,000USD85,694,000USD54,607,000USD63,569,000USD37,080,000USD42,697,000USD79,262,000USD107,991,000USD
    Property Plant Equipment Net97,435,000USD100,310,000USD102,932,000USD103,944,000USD107,444,000USD106,004,000USD121,776,000USD119,550,000USD
    Goodwill1,786,000USD———————
    Accounts Payable13,476,000USD8,696,000USD11,574,000USD9,180,000USD12,345,000USD11,465,000USD16,704,000USD14,694,000USD
    Short Term Debt6,176,000USD6,102,000USD5,872,000USD5,314,000USD5,103,000USD3,560,000USD3,936,000USD4,615,000USD
    Common Stock505,000USD502,000USD498,000USD497,000USD495,000USD495,000USD493,000USD493,000USD
    Retained Earnings-134,760,000USD-142,818,000USD-148,024,000USD-129,715,000USD-138,599,000USD-121,787,000USD-67,576,000USD-33,348,000USD
    Accumulated Other Comprehensive Income-6,967,000USD-6,778,000USD-6,511,000USD-6,527,000USD-5,645,000USD-5,604,000USD-7,031,000USD-5,602,000USD
    Intangible Assets—34,265,000USD30,700,000USD———1,784,214USD—
    Total Liab—98,752,000USD117,435,000USD102,582,000USD101,208,000USD107,392,000USD112,189,000USD109,468,000USD
    Other Current Liab—46,196,000USD51,058,000USD46,059,000USD40,713,000USD47,676,000USD43,119,000USD39,683,000USD
    Capital Stock—502,000USD498,000USD497,000USD495,000USD495,000USD493,000USD493,000USD
    Good Will—1,786,000USD1,786,000USD1,786,000USD1,786,000USD1,786,000USD1,786,000USD1,786,000USD
    Cash—131,864,000USD153,150,000USD176,155,000USD167,131,000USD173,114,000USD144,159,000USD164,003,000USD
    Net Debt—-94,573,000USD-114,797,000USD-137,038,000USD-126,611,000USD-136,436,000USD-105,416,000USD-124,003,000USD
    Short Long Term Debt Total—37,291,000USD38,353,000USD39,117,000USD40,520,000USD36,678,000USD38,743,000USD40,000,000USD
    Inventory—49,784,000USD55,496,000USD53,302,000USD53,107,000USD48,143,000USD43,305,000USD40,361,000USD
    Property Plant Equipment Gross—153,589,000USD153,898,000USD157,213,000USD157,524,000USD153,937,000USD167,825,000USD163,034,000USD
    Common Stock Shares Outstanding—50,900,000shares49,568,000shares49,520,000shares49,520,000shares49,344,000shares49,266,000shares49,731,000shares
    Non Current Assets Total—138,720,000USD150,074,000USD135,153,000USD144,989,000USD130,866,000USD141,584,000USD140,484,000USD
    Non Current Liabilities Total—37,758,000USD48,931,000USD40,945,000USD41,980,000USD39,036,000USD41,883,000USD43,127,000USD
    Non Currrent Assets Other—35,536,000USD1,350,000USD27,446,000USD23,866,000USD19,074,000USD17,234,000USD13,824,000USD
    Net Working Capital—251,404,000USD243,041,000USD259,572,000USD233,564,000USD258,142,000USD297,634,000USD330,765,000USD
    Unclassified Non Current Assets—-33,177,000USD13,306,000USD1,977,000USD-23,854,107,000USD4,002,000USD—5,324,000USD
    Unclassified Non Current Liabilities—37,758,000USD48,931,000USD40,945,000USD41,980,000USD39,036,000USD41,883,000USD43,127,000USD
    Unclassified Equity—500,958,000USD497,723,000USD489,028,000USD479,827,000USD476,373,000USD470,956,000USD466,086,000USD
    Unclassified Current Liabilities———1,084,000USD1,067,000USD5,655,000USD6,547,000USD7,349,000USD
    Other Assets————23,866,000,000USD———
    Long Term Investments——————0USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets461,619,000USD509,524,000USD488,692,000USD418,818,000USD345,778,000USD257,416,000USD207,523,000USD167,339,000USD
    Intangible Assets30,700,000USD15,763,000USD—173,000USD218,000USD270,000USD296,000USD243,000USD
    Other Current Assets13,906,000USD14,879,000USD11,433,000USD9,951,000USD7,873,000USD10,625,000USD4,972,000USD5,045,000USD
    Total Liab117,435,000USD112,189,000USD102,738,000USD82,706,000USD87,220,000USD60,194,000USD47,639,000USD34,913,000USD
    Total Stockholder Equity344,184,000USD397,335,000USD385,954,000USD336,112,000USD258,558,000USD197,222,000USD159,884,000USD132,426,000USD
    Other Current Liab51,058,000USD43,119,000USD36,264,000USD32,602,000USD34,445,000USD23,263,000USD17,467,000USD14,226,000USD
    Common Stock498,000USD493,000USD488,000USD482,000USD477,000USD464,000USD448,000USD442,000USD
    Capital Stock498,000USD493,000USD488,000USD482,000USD477,000USD464,000USD448,000USD442,000USD
    Retained Earnings-148,024,000USD-67,576,000USD-47,368,000USD-68,715,000USD-111,390,000USD-135,891,000USD-141,804,000USD-156,280,000USD
    Good Will1,786,000USD1,786,000USD1,786,000USD1,786,000USD1,786,000USD1,786,000USD1,786,000USD1,786,000USD
    Cash153,150,000USD144,159,000USD183,038,000USD86,480,000USD199,706,000USD152,453,000USD119,968,000USD103,877,000USD
    Cash And Short Term Investments187,536,000USD230,494,000USD220,726,000USD211,639,000USD199,706,000USD152,453,000USD119,968,000USD103,877,000USD
    Total Current Assets311,545,000USD367,940,000USD365,269,000USD311,723,000USD271,411,000USD216,418,000USD174,666,000USD151,572,000USD
    Total Current Liabilities68,504,000USD70,306,000USD65,036,000USD51,716,000USD48,802,000USD41,236,000USD34,478,000USD27,728,000USD
    Net Debt-114,797,000USD-105,416,000USD-147,204,000USD-55,441,000USD-167,645,000USD-141,654,000USD-110,429,000USD-98,540,000USD
    Short Term Debt5,872,000USD3,936,000USD4,367,000USD3,693,000USD3,410,000USD4,224,000USD5,087,000USD4,878,000USD
    Short Long Term Debt Total38,353,000USD38,743,000USD35,834,000USD31,039,000USD32,061,000USD10,799,000USD9,539,000USD5,337,000USD
    Short Term Investments34,386,000USD86,335,000USD37,688,000USD125,159,000USD0USD———
    Net Receivables54,607,000USD79,262,000USD97,980,000USD65,972,000USD46,558,000USD35,229,000USD32,584,000USD25,946,000USD
    Inventory55,496,000USD43,305,000USD35,130,000USD24,161,000USD17,274,000USD18,111,000USD17,142,000USD16,704,000USD
    Accounts Payable11,574,000USD16,704,000USD13,557,000USD11,576,000USD8,699,000USD2,817,000USD8,050,000USD6,524,000USD
    Property Plant Equipment Net102,932,000USD121,776,000USD101,405,000USD81,533,000USD67,728,000USD33,390,000USD25,616,000USD11,451,000USD
    Property Plant Equipment Gross153,898,000USD167,825,000USD137,166,000USD81,533,000USD67,728,000USD33,390,000USD25,616,000USD11,451,000USD
    Accumulated Other Comprehensive Income-6,511,000USD-7,031,000USD-4,113,000USD156,000USD-4,048,000USD-5,545,000USD-3,048,000USD-1,320,000USD
    Common Stock Shares Outstanding49,568,000shares49,125,000shares49,427,000shares49,380,000shares49,456,000shares47,953,000shares46,895,000shares45,257,000shares
    Non Current Assets Total150,074,000USD141,584,000USD123,423,000USD107,095,000USD74,367,000USD40,998,000USD32,857,000USD15,767,000USD
    Non Current Liabilities Total48,931,000USD41,883,000USD37,702,000USD30,990,000USD38,418,000USD18,958,000USD13,161,000USD7,185,000USD
    Non Currrent Assets Other1,350,000USD17,234,000USD3,339,000USD957,000USD822,000USD608,000USD751,000USD887,000USD
    Net Working Capital243,041,000USD297,634,000USD300,233,000USD260,257,000USD222,609,000USD175,182,000USD140,188,000USD123,844,000USD
    Unclassified Non Current Assets13,306,000USD-14,975,000USD5,190,000USD2,963,000USD————
    Unclassified Non Current Liabilities48,931,000USD41,883,000USD37,702,000USD27,346,000USD28,651,000USD-12,383,000USD-7,393,000USD-6,267,000USD
    Unclassified Equity497,723,000USD470,956,000USD436,459,000USD403,707,000USD373,042,000USD337,730,000USD303,840,000USD289,142,000USD
    Long Term Investments—0USD11,703,000USD13,902,000USD0USD———
    Unclassified Current Liabilities—6,547,000USD—3,845,000USD-2,568,000USD5,021,000USD-1,597,000USD-3,780,000USD
    Current Deferred Revenue——10,848,000USD-1,344USD4,816,000USD4,532,000USD3,644,000USD2,100,000USD
    Other Liab———3,644,000USD9,767,000USD12,383,000USD8,051,000USD6,726,000USD
    Other Assets———5,781,000USD4,635,000USD5,552,000USD4,501,000USD2,287,000USD
    Net Tangible Assets———330,233,000USD256,554,000USD195,166,000USD157,802,000USD130,397,000USD
    Deferred Long Term Liab—————222,000USD—1,210,000USD
    Short Long Term Debt—————1,379,000USD1,827,000USD3,780,000USD
    Non Current Liabilities Other—————18,736,000USD12,503,000USD5,516,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Net Income8,058USD5,206,000USD-18,309,000USD8,884,000USD-16,812,000USD-54,211,000USD-34,228,000USD9,980,000USD
    Depreciation2,390USD2,211,000USD2,416,000USD2,000,000USD1,975,000USD2,337,000USD2,375,000USD1,757,000USD
    Stock Based Compensation6,560USD4,823,000USD8,613,000USD8,158,000USD7,802,000USD6,015,000USD4,669,000USD7,160,000USD
    Financing Cash Flow-1,502USD———————
    Other Non Cash Items—5,943,000USD4,640,000USD4,506,000USD5,248,000USD11,751,000USD-1,296,000USD-27,758,000USD
    Change To Account Receivables—-31,921,000USD9,830,000USD-25,855,000USD5,689,000USD38,170,000USD26,196,000USD-10,139,000USD
    Change To Inventory—4,088,000USD-4,532,000USD-1,244,000USD-4,901,000USD-6,304,000USD-4,038,000USD-1,091,000USD
    Change In Working Capital—-42,688,000USD924,000USD-30,787,000USD-15,867,000USD29,403,000USD25,579,000USD12,690,000USD
    Total Cash From Operating Activities—-21,695,000USD-3,914,000USD2,667,000USD-27,249,000USD-5,734,000USD642,000USD3,816,000USD
    Capital Expenditures—-443,000USD-1,677,000USD-883,000USD-1,792,000USD-1,468,000USD-5,725,000USD11,438,000USD
    Free Cash Flow—-22,138,000USD-5,591,000USD1,784,000USD-29,041,000USD-7,202,000USD-5,083,000USD15,254,000USD
    Investments—2,590,000USD-17,738,000USD5,283,000USD25,120,000USD35,351,000USD-19,495,000USD-35,241,000USD
    Total Cashflows From Investing Activities—2,147,000USD-19,415,000USD5,283,000USD25,120,000USD35,351,000USD-19,495,000USD-35,241,000USD
    Net Borrowings—0USD0USD0USD0USD-42,000USD-41,000USD-42,000USD
    Total Cash From Financing Activities—-1,693,000USD-50,000USD983,000USD-4,540,000USD-948,000USD-110,000USD1,615,000USD
    Sale Purchase Of Stock—-1,867,000USD-164,000USD-1,982,000USD-4,479,000USD-1,283,000USD-109,000USD0USD
    Change In Cash—-21,286,000USD-23,005,000USD9,024,000USD-5,983,000USD28,955,000USD-19,844,000USD-28,773,000USD
    Begin Period Cash Flow—153,150,000USD176,155,000USD167,131,000USD173,114,000USD144,159,000USD164,003,000USD192,776,000USD
    End Period Cash Flow—131,864,000USD153,150,000USD176,155,000USD167,131,000USD173,114,000USD144,159,000USD164,003,000USD
    Other Cashflows From Investing Activities—-211,000USD1,675,466USD24,237,000USD-39,439,000USD——-17,669,000USD
    Other Cashflows From Financing Activities—-1,693,000USD-164,000USD2,964,000USD-73,000USD377,000USD40,000USD1,657,000USD
    Unclassified Operating Cash Flow—2,810,000USD-2,198,000USD9,906,000USD-9,595,000USD-1,029,000USD3,543,000USD—
    Unclassified Financing Cash Flow—1,867,000USD——————
    Issuance Of Capital Stock——0USD1,000USD——0USD0USD
    Unclassified Investing Cash Flow——-1,675,466USD-23,354,000USD41,231,000USD1,468,000USD5,725,000USD6,231,000USD
    SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-80,448,000USD-20,208,000USD21,347,000USD39,005,000USD27,511,000USD5,913,000USD14,048,000USD4,968,000USD
    Depreciation8,319,000USD6,891,000USD5,124,000USD4,509,000USD3,642,000USD3,095,000USD3,699,000USD2,464,000USD
    Stock Based Compensation30,588,000USD27,210,000USD23,516,000USD20,371,000USD14,605,000USD12,146,000USD10,547,000USD6,762,000USD
    Other Non Cash Items26,554,000USD3,644,000USD2,182,000USD2,302,000USD2,111,000USD3,410,000USD2,228,000USD2,619,000USD
    Change To Account Receivables27,834,000USD16,493USD-32,760,000USD-19,601,000USD-8,868,000USD-3,974,000USD-4,502,000USD-6,040,000USD
    Change To Inventory-16,981,000USD-10,000USD-14,361,000USD-7,943,000USD66,000USD-1,390,000USD-950,000USD-4,194,000USD
    Change In Working Capital-16,327,000USD-5,402,000USD-40,839,000USD-29,128,000USD-2,392,000USD-2,764,000USD-1,246,000USD-4,487,000USD
    Total Cash From Operating Activities-34,230,000USD15,725,000USD14,594,000USD35,715,000USD43,962,000USD20,951,000USD25,795,000USD12,767,000USD
    Capital Expenditures-5,820,000USD-23,394,000USD-18,188,000USD-18,108,000USD-13,645,000USD-8,404,000USD-10,178,000USD-2,245,000USD
    Free Cash Flow-40,050,000USD-7,669,000USD-3,594,000USD17,607,000USD30,317,000USD12,547,000USD15,617,000USD10,522,000USD
    Investments52,159,000USD-59,217,000USD74,347,000USD-156,376,000USD-13,645,000USD-8,404,000USD-10,178,000USD-2,245,000USD
    Total Cashflows From Investing Activities46,339,000USD-59,217,000USD74,347,000USD-156,376,000USD-13,645,000USD-8,404,000USD-10,178,000USD-2,245,000USD
    Net Borrowings-42,000USD-165,000USD-161,000USD-126,000USD-1,645,000USD-515,000USD-2,018,000USD-2,654,000USD
    Total Cash From Financing Activities-4,555,000USD5,724,000USD7,415,000USD8,297,000USD17,793,000USD19,571,000USD149,000USD74,639,000USD
    Sale Purchase Of Stock-6,461,000USD-1,505,000USD-2,097,000USD0USD0USD20,646,000USD3,461,000USD-54,000USD
    Issuance Of Capital Stock3,000USD2,000USD1,000USD1,000USD1,000USD1,000USD2,000USD72,152,000USD
    Change In Cash8,991,000USD-38,879,000USD96,558,000USD-113,226,000USD47,253,000USD32,485,000USD15,969,000USD85,358,000USD
    Begin Period Cash Flow144,159,000USD183,038,000USD86,480,000USD199,706,000USD152,453,000USD119,968,000USD103,999,000USD18,641,000USD
    End Period Cash Flow153,150,000USD144,159,000USD183,038,000USD86,480,000USD199,706,000USD152,453,000USD119,968,000USD103,999,000USD
    Other Cashflows From Investing Activities198,000USD1,091,000USD—-138,268,000USD-13,645USD—-83,000USD—
    Other Cashflows From Financing Activities-1,520,000USD7,392,000USD9,672,000USD8,422,000USD19,437,000USD20,646,000USD3,459,000USD4,448,000USD
    Unclassified Operating Cash Flow-2,916,000USD3,590,000USD3,264,000USD-1,344,000USD-1,515,000USD—-3,481,000USD—
    Unclassified Financing Cash Flow3,468,000USD————-21,206,000USD-4,753,000USD78,094,000USD
    Unclassified Investing Cash Flow—22,303,000USD18,188,000USD156,376,000USD13,658,645USD8,404,000USD10,261,000USD2,245,000USD
    Dividends Paid——-9,673USD————-5,195,000USD
    Change To Liabilities———1,805,000USD108,000USD7,009,000USD5,878,000USD6,576,000USD
    Cash And Cash Equivalents Changes—————32,118,000USD15,766,000USD85,161,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2025Quarterly · 2025-06-30GeographyChina5,299,000USD0000950170-25-103982
    Q2 2025Quarterly · 2025-06-30GeographyJapan10,915,000USD0000950170-25-103982
    Q2 2025Quarterly · 2025-06-30GeographyOther Countries18,178,000USD0000950170-25-103982
    Q2 2025Quarterly · 2025-06-30GeographySouth Korea4,293,000USD0000950170-25-103982
    Q1 2025Quarterly · 2025-03-31GeographyChina-877,000USD0000718937-26-000023
    Q1 2025Quarterly · 2025-03-31GeographyJapan11,395,000USD0000718937-26-000023
    Q1 2025Quarterly · 2025-03-31GeographyOther Countries19,090,000USD0000718937-26-000023
    Q1 2025Quarterly · 2025-03-31GeographySouth Korea7,522,000USD0000718937-26-000023
    Q4 2024Quarterly · 2024-12-31GeographyChina7,751,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyJapan10,937,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyOther Countries25,381,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyChina162,287,000USD0000718937-26-000004
    FY 2024Yearly · 2024-12-31GeographyJapan41,814,000USD0000718937-26-000004
    FY 2024Yearly · 2024-12-31GeographyOther Countries89,904,000USD0000718937-26-000004
    Q3 2024Quarterly · 2024-09-30GeographyChina52,468,000USD0001193125-25-266879
    Q3 2024Quarterly · 2024-09-30GeographyJapan10,534,000USD0001193125-25-266879
    Q3 2024Quarterly · 2024-09-30GeographyOther Countries20,907,000USD0001193125-25-266879
    Q2 2024Quarterly · 2024-06-30GeographyChina63,519,000USD0000950170-25-103982
    Q2 2024Quarterly · 2024-06-30GeographyJapan9,887,000USD0000950170-25-103982
    Q2 2024Quarterly · 2024-06-30GeographyOther Countries16,276,000USD0000950170-25-103982
    Q2 2024Quarterly · 2024-06-30GeographySouth Korea3,924,000USD0000950170-25-103982
    Q1 2024Quarterly · 2024-03-31GeographyChina38,549,000USD0000950170-25-065665
    Q1 2024Quarterly · 2024-03-31GeographyJapan10,456,000USD0000950170-25-065665
    Q1 2024Quarterly · 2024-03-31GeographyOther Countries16,689,000USD0000950170-25-065665
    Q1 2024Quarterly · 2024-03-31GeographySouth Korea6,727,000USD0000950170-25-065665
    Q4 2023Quarterly · 2023-12-31GeographyChina39,853,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31GeographyJapan9,942,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31GeographyOther Countries22,318,000USDLegacy provider
    FY 2023Yearly · 2023-12-31GeographyChina184,569,000USD0000718937-26-000004
    FY 2023Yearly · 2023-12-31GeographyJapan38,468,000USD0000718937-26-000004
    FY 2023Yearly · 2023-12-31GeographyOther Countries82,157,000USD0000718937-26-000004
    Q3 2023Quarterly · 2023-09-30GeographyChina48,287,000USD0000950170-24-118973
    Q3 2023Quarterly · 2023-09-30GeographyJapan9,175,000USD0000950170-24-118973
    Q3 2023Quarterly · 2023-09-30GeographyOther Countries18,682,000USD0000950170-24-118973
    FY 2022Yearly · 2022-12-31GeographyChina148,167,000USD0000950170-25-024813
    FY 2022Yearly · 2022-12-31GeographyJapan43,093,000USD0000950170-25-024813
    FY 2022Yearly · 2022-12-31GeographyOther Countries78,452,000USD0000950170-25-024813
    FY 2021Yearly · 2021-12-31GeographyChina107,333,000USD0000950170-24-020572
    FY 2021Yearly · 2021-12-31GeographyJapan40,973,000USD0000950170-24-020572
    FY 2021Yearly · 2021-12-31GeographyOther Countries72,071,000USD0000950170-24-020572
    Q2 2021Quarterly · 2021-06-30ProductImplantable Collamer Lenses59,235,000USD0001564590-21-040819
    Q2 2021Quarterly · 2021-06-30ProductIntraocular Lenses3,074,000USD0001564590-21-040819
    Q2 2021Quarterly · 2021-06-30ProductOther Surgical Products58,000USD0001564590-21-040819
    Q1 2021Quarterly · 2021-03-31ProductImplantable Collamer Lenses46,501,000USD0001564590-21-024058
    Q1 2021Quarterly · 2021-03-31ProductIntraocular Lenses3,725,000USD0001564590-21-024058
    Q1 2021Quarterly · 2021-03-31ProductOther Surgical Products526,000USD0001564590-21-024058
    FY 2020Yearly · 2020-12-31GeographyChina71,692,000USD0001564590-23-002249
    FY 2020Yearly · 2020-12-31GeographyJapan34,986,000USD0001564590-23-002249
    FY 2020Yearly · 2020-12-31GeographyOther Countries50,624,000USD0001564590-23-002249
    Q4 2020Quarterly · 2020-12-31ProductImplantable Collamer Lenses39,846,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductIntraocular Lenses3,694,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductOther Surgical Products2,458,000USDLegacy provider
    FY 2020Yearly · 2020-12-31ProductImplantable Collamer Lenses141,407,000USD0001564590-21-008098
    FY 2020Yearly · 2020-12-31ProductIntraocular Lenses13,574,000USD0001564590-21-008098
    FY 2020Yearly · 2020-12-31ProductOther Surgical Products8,479,000USD0001564590-21-008098
    Q3 2020Quarterly · 2020-09-30ProductImplantable Collamer Lenses41,493,000USD0001564590-20-050470
    Q3 2020Quarterly · 2020-09-30ProductIntraocular Lenses3,325,000USD0001564590-20-050470
    Q3 2020Quarterly · 2020-09-30ProductOther Surgical Products2,263,000USD0001564590-20-050470
    Q2 2020Quarterly · 2020-06-30ProductImplantable Collamer Lenses30,728,000USD0001564590-21-040819
    Q2 2020Quarterly · 2020-06-30ProductIntraocular Lenses2,561,000USD0001564590-21-040819
    Q2 2020Quarterly · 2020-06-30ProductOther Surgical Products1,905,000USD0001564590-21-040819
    Q1 2020Quarterly · 2020-03-31ProductImplantable Collamer Lenses29,340,000USD0001564590-21-024058
    Q1 2020Quarterly · 2020-03-31ProductIntraocular Lenses3,994,000USD0001564590-21-024058
    Q1 2020Quarterly · 2020-03-31ProductOther Surgical Products1,853,000USD0001564590-21-024058
    FY 2019Yearly · 2019-12-31GeographyChina64,820,000USD0001564590-22-006264
    FY 2019Yearly · 2019-12-31GeographyJapan26,881,000USD0001564590-22-006264
    FY 2019Yearly · 2019-12-31GeographyOther Countries50,378,000USD0001564590-22-006264
    Q4 2019Quarterly · 2019-12-31ProductImplantable Collamer Lenses33,289,000USDLegacy provider
    Q4 2019Quarterly · 2019-12-31ProductIntraocular Lenses3,705,000USDLegacy provider
    Q4 2019Quarterly · 2019-12-31ProductOther Surgical Products1,889,000USDLegacy provider
    FY 2019Yearly · 2019-12-31ProductImplantable Collamer Lenses129,322,000USD0001564590-21-008098
    FY 2019Yearly · 2019-12-31ProductIntraocular Lenses15,689,000USD0001564590-21-008098
    FY 2019Yearly · 2019-12-31ProductOther Surgical Products5,174,000USD0001564590-21-008098
    Q3 2019Quarterly · 2019-09-30ProductImplantable Collamer Lenses33,815,000USD0001564590-20-050470
    Q3 2019Quarterly · 2019-09-30ProductIntraocular Lenses4,093,000USD0001564590-20-050470
    Q3 2019Quarterly · 2019-09-30ProductOther Surgical Products1,147,000USD0001564590-20-050470
    FY 2018Yearly · 2018-12-31GeographyChina46,070,000USD0001564590-21-008098
    FY 2018Yearly · 2018-12-31GeographyJapan23,151,000USD0001564590-21-008098
    FY 2018Yearly · 2018-12-31GeographyOther Countries47,417,000USD0001564590-21-008098
    FY 2018Yearly · 2018-12-31ProductImplantable Collamer Lenses101,082,000USD0001564590-21-008098
    FY 2018Yearly · 2018-12-31ProductIntraocular Lenses16,193,000USD0001564590-21-008098
    FY 2018Yearly · 2018-12-31ProductOther Surgical Products6,679,000USD0001564590-21-008098
    FY 2017Yearly · 2017-12-31GeographyChina24,473,000USD0001564590-20-006791
    FY 2017Yearly · 2017-12-31GeographyJapan18,125,000USD0001564590-20-006791
    FY 2017Yearly · 2017-12-31GeographyOther Countries40,119,000USD0001564590-20-006791
    FY 2017Yearly · 2017-12-31ProductImplantable Collamer Lenses68,325,000USD0001564590-20-006791
    FY 2017Yearly · 2017-12-31ProductIntraocular Lenses17,258,000USD0001564590-20-006791
    FY 2017Yearly · 2017-12-31ProductOther Surgical Products5,028,000USD0001564590-20-006791
    FY 2016Yearly · 2016-12-31ProductImplantable Collamer Lenses59,111,000USD0001564590-19-003674
    FY 2016Yearly · 2016-12-31ProductIntraocular Lenses19,706,000USD0001564590-19-003674
    FY 2016Yearly · 2016-12-31ProductOther Surgical Products3,615,000USD0001564590-19-003674
    FY 2015Yearly · 2015-12-31ProductImplantable Collamer Lenses51,543,000USD0001144204-18-011838
    FY 2015Yearly · 2015-12-31ProductIntraocular Lenses19,857,000USD0001144204-18-011838
    FY 2015Yearly · 2015-12-31ProductOther Surgical Products5,723,000USD0001144204-18-011838
    FY 2014Yearly · 2014-12-31ProductImplantable Collamer Lenses44,047,000USD0001144204-17-012557
    FY 2014Yearly · 2014-12-31ProductIntraocular Lenses24,336,000USD0001144204-17-012557
    FY 2014Yearly · 2014-12-31ProductOther Surgical Products6,604,000USD0001144204-17-012557
    FY 2013Yearly · 2013-12-31ProductImplantable Collamer Lenses44,128,000USD0001144204-16-087343
    FY 2013Yearly · 2013-12-31ProductIntraocular Lenses24,153,000USD0001144204-16-087343
    FY 2013Yearly · 2013-12-31ProductOther Surgical Products3,934,000USD0001144204-16-087343

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.